We’ve revised our projections in an unprecedented “mid-year” update, and it’s tough news across the industry. Growth estimates dropped from 4.2% to 1.7% for 2022, and 2023 will remain slow before anticipated recovery in 2024.
GDP is strong and unemployment is low, but inflation is real and supplement supplies are overstocked from ingredient suppliers all the way down to consumer cabinets. It’s not just about recession and it’s a confusing picture for the supplement industry—especially after the pandemic-driven sales boom of the past three years.
How does this all play into what's to come? Dive into this special report to see what shifts are predicted in the supplement industry. | 
